PL362766A1 - Nowe pochodne imidazolu, sposób ich wytwarzania iich zastosowanie - Google Patents

Nowe pochodne imidazolu, sposób ich wytwarzania iich zastosowanie

Info

Publication number
PL362766A1
PL362766A1 PL01362766A PL36276601A PL362766A1 PL 362766 A1 PL362766 A1 PL 362766A1 PL 01362766 A PL01362766 A PL 01362766A PL 36276601 A PL36276601 A PL 36276601A PL 362766 A1 PL362766 A1 PL 362766A1
Authority
PL
Poland
Prior art keywords
compound
production method
imidazole derivatives
sub
mixture
Prior art date
Application number
PL01362766A
Other languages
English (en)
Other versions
PL204934B1 (pl
Inventor
Akihiro Tasaka
Takenori Hitaka
Nobuyuki Matsunaga
Masami Kusaka
Mari Adachi
Isao Aoki
Akio Ojida
Original Assignee
Takeda Pharmaceutical Company Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical Company Limited filed Critical Takeda Pharmaceutical Company Limited
Publication of PL362766A1 publication Critical patent/PL362766A1/pl
Publication of PL204934B1 publication Critical patent/PL204934B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Przedmiotem niniejszego wynalazku jest związek wykazujący aktywność hamującą sterydową C<sub>17-29</sub>-liazę i przydatny do leczenia i zapobiegania nowotworom, takim jak rozrost stercz, rak piersi i tym podobne, oraz sposób wydajnego rozdzielania optycznie czynnej postaci tego związku z mieszaniny jego izomerów optycznych, związek o wzorze (I), w którym każdy symbol jest taki, jak zdefiniowano w opisie, jego sól lub przedlek, oraz sposób otrzymywania optycznie czynnego związku przez optyczne rozdzielanie mieszaniny izomerów optycznych z użyciem czynnika rozdzielającego, takiego jak monoanilid kwasu winowego i tym podobne.
PL362766A 2000-11-17 2001-11-16 Pochodne imidazolu i ich sole diastereomeryczne, kompozycje farmaceutyczne i środki do zmniejszania poziomu androgenu zawierające te pochodne oraz sposoby ich wytwarzania PL204934B1 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2000351780 2000-11-17
JP2001247618 2001-08-17
JP2001336880 2001-11-01
PCT/JP2001/010002 WO2002040484A2 (en) 2000-11-17 2001-11-16 Novel imidazole derivatives, production method thereof and use thereof

Publications (2)

Publication Number Publication Date
PL362766A1 true PL362766A1 (pl) 2004-11-02
PL204934B1 PL204934B1 (pl) 2010-02-26

Family

ID=27345219

Family Applications (1)

Application Number Title Priority Date Filing Date
PL362766A PL204934B1 (pl) 2000-11-17 2001-11-16 Pochodne imidazolu i ich sole diastereomeryczne, kompozycje farmaceutyczne i środki do zmniejszania poziomu androgenu zawierające te pochodne oraz sposoby ich wytwarzania

Country Status (27)

Country Link
US (1) US7141598B2 (pl)
EP (2) EP1334106B1 (pl)
JP (2) JP3753971B2 (pl)
KR (3) KR100725442B1 (pl)
CN (3) CN100572363C (pl)
AR (1) AR034854A1 (pl)
AT (2) ATE533768T1 (pl)
AU (3) AU1429602A (pl)
BR (1) BR0115306B1 (pl)
CA (1) CA2429133C (pl)
CY (1) CY1105423T1 (pl)
DE (1) DE60119963T2 (pl)
DK (1) DK1334106T3 (pl)
ES (1) ES2260303T3 (pl)
HK (1) HK1056168A1 (pl)
HU (1) HU229408B1 (pl)
IL (2) IL155624A0 (pl)
MX (1) MXPA03004347A (pl)
MY (1) MY134929A (pl)
NO (1) NO326366B1 (pl)
NZ (1) NZ526387A (pl)
PE (1) PE20020596A1 (pl)
PL (1) PL204934B1 (pl)
PT (1) PT1334106E (pl)
SI (1) SI1334106T1 (pl)
TW (1) TWI306099B (pl)
WO (1) WO2002040484A2 (pl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1471056B1 (en) * 2002-01-10 2012-07-11 Takeda Pharmaceutical Company Limited Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same
JP4745616B2 (ja) * 2003-02-26 2011-08-10 武田薬品工業株式会社 安定化されたイミダゾール誘導体含有医薬組成物、イミダゾール誘導体の安定化方法
WO2004075890A1 (ja) * 2003-02-26 2004-09-10 Takeda Pharmaceutical Company 安定化されたイミダゾール誘導体含有医薬組成物、イミダゾ－ル誘導体の安定化方法
EP1607092A4 (en) * 2003-03-17 2010-12-15 Takeda Pharmaceutical CONTROLLED RELEASE COMPOSITIONS
JP4837895B2 (ja) * 2003-03-17 2011-12-14 武田薬品工業株式会社 放出制御組成物
WO2005111028A1 (en) * 2004-05-03 2005-11-24 Janssen Pharmaceutica N.V. Novel indole derivatives as selective androgen receptor modulators (sarms)
EP1749005A1 (en) * 2004-05-28 2007-02-07 Speedel Experimenta AG Tetrahydro-imidazo ¬1,5-a| pyridin derivatives as aldosterone synthase inhibitors
WO2006093353A1 (ja) 2005-03-03 2006-09-08 Takeda Pharmaceutical Company Limited 放出制御組成物
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
AR056888A1 (es) * 2005-12-09 2007-10-31 Speedel Experimenta Ag Derivados de heterociclil imidazol
JP5230448B2 (ja) * 2006-02-10 2013-07-10 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 選択的アンドローゲン受容体モジュレーターとして有用な新イミダゾロピラゾール誘導体
TW200804284A (en) * 2006-03-31 2008-01-16 Speedel Experimenta Ag Process for preparing 6,7-dihydro-5H-imidazo[1,5-a]pyridin-8-one
US20100261689A1 (en) * 2007-10-29 2010-10-14 Masuo Yamaoka Pyrrolo [1,2-c] imidazole derivatives for use in the prophylaxis or treatment of cancer which is refractory to known cancer therapies
JOP20190230A1 (ar) * 2009-01-15 2017-06-16 Incyte Corp طرق لاصلاح مثبطات انزيم jak و المركبات الوسيطة المتعلقة به
AR083916A1 (es) * 2010-11-18 2013-04-10 Takeda Pharmaceutical Metodo para tratar el cancer de mama y cancer de ovarios
AR085743A1 (es) 2011-04-01 2013-10-23 Takeda Pharmaceutical Preparacion solida
CN103608334B (zh) 2011-06-15 2015-12-23 武田药品工业株式会社 咪唑衍生物的制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4728645A (en) * 1982-12-21 1988-03-01 Ciba-Geigy Corporation Substituted imidazo[1,5-A]pyridine derivatives and other substituted bicyclic derivatives, useful as aromatase inhibitors
NZ221729A (en) 1986-09-15 1989-07-27 Janssen Pharmaceutica Nv Imidazolyl methyl-substituted benzimidazole derivatives and pharmaceutical compositions
NZ224288A (en) 1987-04-22 1989-12-21 Merrell Dow Pharma 17b-(cyclopropylamino)androst-5-en-3b-ol and related compounds and methods using these for treatment of non-humans
US5057521A (en) * 1988-10-26 1991-10-15 Ciba-Geigy Corporation Use of bicyclic imidazole compounds for the treatment of hyperaldosteronism
US4966898A (en) 1989-08-15 1990-10-30 Merrell Dow Pharmaceuticals Inc. 4-substituted 17β-(cyclopropylamino)androst-5-en-3β-ol and related compounds useful as C17-20 lyase inhibitors
AU659632B2 (en) 1991-03-01 1995-05-25 Electrostatic Technology, Inc. Powder coating method for producing circuit board laminae and the like
EP0625155B1 (en) 1992-01-27 2001-08-08 Janssen Pharmaceutica N.V. Pyrroloimidazolyl and imidazopyridinyl substituted 1h-benzimidazole derivatives as aromatase inhibitors
US5457102A (en) 1994-07-07 1995-10-10 Janssen Pharmaceutica, N.V. Pyrroloimidazolyl and imidazopyridinyl substituted 1H-benzimidazole derivatives
DK0633893T3 (da) 1992-03-31 2000-04-17 Btg Int Ltd 17-Substituerede steroider, der er nyttige ved cancerbehandling
GB9310635D0 (en) 1993-05-21 1993-07-07 Glaxo Group Ltd Chemical compounds
HUT75871A (en) 1993-09-30 1997-05-28 Yamanouchi Co Azole derivatives and pharmaceutical compositions thereof
AU3846395A (en) 1994-11-07 1996-05-31 Janssen Pharmaceutica N.V. Compositions comprising carbazoles and cyclodextrins
AU6015796A (en) 1995-06-14 1997-01-15 Yamanouchi Pharmaceutical Co., Ltd. Fused imidazole derivatives and medicinal composition thereof
CN1251577A (zh) 1997-02-21 2000-04-26 武田药品工业株式会社 稠环化合物及其生产和应用
KR20000069426A (ko) 1997-10-02 2000-11-25 이시가와 데쯔로 신규의 디히드로나프탈렌 화합물 및 그 제조방법
WO1999054309A1 (en) 1998-04-23 1999-10-28 Takeda Chemical Industries, Ltd. Naphthalene derivatives, their production and use
PE20010781A1 (es) * 1999-10-22 2001-08-08 Takeda Chemical Industries Ltd Compuestos 1-(1h-imidazol-4-il)-1-(naftil-2-sustituido)etanol, su produccion y utilizacion

Also Published As

Publication number Publication date
MY134929A (en) 2008-01-31
CN1474819A (zh) 2004-02-11
KR20080002929A (ko) 2008-01-04
CY1105423T1 (el) 2010-04-28
EP1334106A2 (en) 2003-08-13
KR20030048156A (ko) 2003-06-18
DE60119963D1 (de) 2006-06-29
NO326366B1 (no) 2008-11-17
EP1681290B1 (en) 2011-11-16
CN1900079A (zh) 2007-01-24
ATE533768T1 (de) 2011-12-15
JP2006045239A (ja) 2006-02-16
CN100572363C (zh) 2009-12-23
AU2002214296C1 (en) 2006-04-13
IL155624A0 (en) 2003-11-23
PL204934B1 (pl) 2010-02-26
TWI306099B (en) 2009-02-11
NO20032234D0 (no) 2003-05-16
NZ526387A (en) 2004-02-27
US7141598B2 (en) 2006-11-28
ATE327237T1 (de) 2006-06-15
PT1334106E (pt) 2006-08-31
HK1056168A1 (en) 2004-02-06
ES2260303T3 (es) 2006-11-01
BR0115306A (pt) 2004-02-10
EP1681290A3 (en) 2006-07-26
HUP0400549A3 (en) 2004-09-28
DE60119963T2 (de) 2006-10-05
EP1681290B9 (en) 2013-06-19
CA2429133C (en) 2009-08-18
KR20050105287A (ko) 2005-11-03
CN1680336A (zh) 2005-10-12
KR100725442B1 (ko) 2007-06-07
HUP0400549A2 (hu) 2004-06-28
AU1429602A (en) 2002-05-27
AU2002214296B2 (en) 2005-09-29
IL155624A (en) 2006-12-31
CN1329394C (zh) 2007-08-01
MXPA03004347A (es) 2004-05-04
WO2002040484A2 (en) 2002-05-23
DK1334106T3 (da) 2006-09-18
SI1334106T1 (sl) 2006-10-31
AU2005225035B2 (en) 2007-02-22
PE20020596A1 (es) 2002-08-13
WO2002040484A3 (en) 2002-09-26
EP1334106B1 (en) 2006-05-24
EP1681290A2 (en) 2006-07-19
JP2003201282A (ja) 2003-07-18
JP4427496B2 (ja) 2010-03-10
AR034854A1 (es) 2004-03-24
JP3753971B2 (ja) 2006-03-08
KR100809899B1 (ko) 2008-03-10
BR0115306B1 (pt) 2013-12-24
NO20032234L (no) 2003-07-16
HU229408B1 (hu) 2013-12-30
US20040033935A1 (en) 2004-02-19
AU2005225035A1 (en) 2005-11-10
CA2429133A1 (en) 2002-05-23

Similar Documents

Publication Publication Date Title
PL362766A1 (pl) Nowe pochodne imidazolu, sposób ich wytwarzania iich zastosowanie
CO5650246A2 (es) Derivados de indazolil(indolil)maleimida sustituidos como inhibidores de cinasa
ATE363473T1 (de) Substituierte pyrazoloverbindungen zur behandlung von entzündungen
MY134783A (en) Rho-kinase inhibitors
MY142915A (en) Rho-kinase inhibitors
CY1107747T1 (el) Υποκατεστημενα τετρακυκλικα παραγωγα πυρρολοκινολονης χρησιμα ως αναστολεις της φωσφοδιεστερασης
NO20020214D0 (no) Substituerte oksozaheterocyklylforbindelser
TNSN06074A1 (en) Pyrimidine derivatives for the treatment of abnormal cell growth
ATE433447T1 (de) Pyrimiidinverbindungen
NO20054361D0 (no) Benzensylfonamidderivater, fremgangsmate for fremstilling og anvendelse derav for behandlig av smerte
HK1085675A1 (en) Anticancer compounds
DE60228098D1 (de) Pyridin-substituierte furanderivate als raf-kinase inhibitoren
ES2243579T3 (es) Derivados de pirazolopirideno.
WO2004084812A3 (en) Tamandarin analogs and fragments thereof and methods of making and using
MX2023002224A (es) Compuestos heterociclicos.
NO20043016L (no) 6-aminomorfinan-derivater, fremgangsmate for fremstilling og anvendelse derav
CR20230382A (es) Derivados de tetrahidroazepina bicíclicos para el tratamiento del cáncer
DK1056704T3 (da) Antitumormidler
NO20020161L (no) Vitamin D3-analoger
MY138466A (en) Aminoalkoxyndoles as 5-ht6-receptor ligands for the treatment of cns-disorders
BR0318521A (pt) arilindenopiridinas e arilindenopirimidinas e métodos terapêuticos e profiláticos relacionados
IL150310A0 (en) Substituted homopiperidinyl benzimidazole analogues as fundic relaxants
BR0116123A (pt) Carbazóis antitumorais
AR022130A1 (es) Nuevos derivados de arilalcanoilo, los procesos para su preparacion, uso y las composiciones farmaceuticas que los contienen
MXPA05003909A (es) Compuestos de benzopiranona, composiciones de los mismos, y metodos para el tratamiento o prevencion del cancer.